Publikasjoner - Legemidler ved graviditet og amming

Avdeling for klinisk farmakologi

  • Nezvalova-Henriksen K, Wood M, Spigset O, Nordeng H. Effect of prenatal ibuprofen exposure on birth weight and gestational age: a population-based sibling study. PLoS One 2016; 11: e0166971.

  • Nezvalova-Henriksen K, Spigset O, Brandlistuen RE, Ystrøm E, Koren G, Nordeng H. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birth weight and gestational age: a sibling-controlled cohort study. Int J Epidemiol 2016; 45: 2018-29.
  • Spigset O, Nordeng H. Safety of psychotropic drugs in pregnancy and breastfeeding. In: Spina E, Trifirò G (eds). Pharmacovigilance in psychiatry. Cham, Switzerland: Springer, 2016, pp. 299-319. ISBN 978-3-319-24739-7.
  • Nordeng H, Kaplan YC, Spigset O. Antipsychotics and breastfeeding. In: Uguz F (ed.). Psychiatric disorders during the postpartum period. Nova Publishers, Hauppauge NY, 2016, pp. 143-151. ISBN 978-1-634-84579-3.
  • Westin AA, Brekke M, Molden E, Skogvoll E, Castberg I, Spigset O. Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway. BMJ Open 2017; 7: e015738.
  • Lupattelli A, Spigset O, Björnsdottir I, Hameen-Antilla K, Mårdby AC, Panchaud A et al. Patterns and factors associated with low adherence to psychotropic medications during pregnancy – a cross-sectional, multinational web-based study. Depess Anxiety 2015; 32; 426-36.
  • Amundsen S, Nordeng H, Nezvalová-Henriksen K, Stovner LJ, Spigset O. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nature Rev Neurol 2015; 11: 209-19.
  • Lupattelli A, Spigset O, Torgersen L, Zervas S, Hatle M, Reichborn-Kjennerud T, Bulik CM, Nordeng H. Medication use before, during and after pregnancy among women with eating disorders: a study from the Norwegian Mother and Child Cohort Study. Plos One 2015; 10: e0133045.
  • Bjørk M, Veiby G, Spigset O, Gilhus NE. Using the Norwegian Mother and Child Cohort Study to determine risk factors for delatyed development and neuropsychiatric symptoms in the offspring of parents with epilepsy. Norwegian Journal of Epidemiology (Norsk Epidemiologi) 2014; 24: 79-89.
  • Lupattelli A, Spigset O, Koren G, Nordeng H. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child cohort study. J Clin Psychopharmacol 2014; 34: 143-8.
  • Lupattelli A, Spigset O, Nordeng H. Adherence to medication for chronic disorders during pregnancy – results from a multinational study. Int J Clin Pharm 2014; 36: 145-53.
  • Nordeng H, Gjerdalen G, Brede WR, Michelsen LS, Spigset O. Transfer of aripiprazole to breast milk. J Clin Psychopharmacol 2014; 34: 272-5.
  • Lupattelli A, Spigset O, Twigg MJ, Zagarodinkova K, Mårdby AC, Morettii ME et al. Medication use in pregnany: a cross-sectional, multinational web-based study. BMJ Open 2014, 4: e004365.
  • Bjørk MH, Veiby G, Reiter S, Berle JØ, Daltveit AK, Spigset O, Engelsen B, Gilhus NE. Depression and anxiety in women with epilepsy during pregnancy and after delivery: A prospective cohort study of frequency, risk factors, medication and prognosis. Epilepsia 2015; 56: 28-39.